|
humans |
76 |
|
female |
56 |
|
adult |
46 |
|
middle aged |
39 |
|
immunohistochemistry |
38 |
|
male |
33 |
|
aged |
30 |
|
pregnancy |
28 |
|
molecular sequence data |
27 |
|
animals |
23 |
|
reverse transcriptase polymerase chain reaction |
21 |
|
adolescent |
20 |
|
cervical cancer |
20 |
|
hong kong - epidemiology |
20 |
|
prognosis |
19 |
|
genetic predisposition to disease |
18 |
|
cohort studies |
17 |
|
polymerase chain reaction |
17 |
|
aged, 80 and over |
16 |
|
gestational trophoblastic disease |
16 |
|
ovarian cancer |
16 |
|
chemotherapy |
15 |
|
diagnosis, differential |
15 |
|
gene expression regulation, neoplastic |
15 |
|
human papillomavirus |
15 |
|
blotting, western |
14 |
|
cell line, tumor |
14 |
|
choriocarcinoma |
14 |
|
fallopian tube |
14 |
|
in situ hybridization |
14 |
|
neoplasm staging |
14 |
|
antigens, cd - genetics |
13 |
|
apoptosis |
13 |
|
base sequence |
13 |
|
cell adhesion molecules - genetics |
13 |
|
cell proliferation |
13 |
|
dna methylation |
13 |
|
gestational age |
13 |
|
l-lactate dehydrogenase - blood |
13 |
|
mutation |
13 |
|
polymorphism, single nucleotide - genetics |
13 |
|
tubal ectopic pregnancy |
13 |
|
biopsy |
12 |
|
case-control studies |
12 |
|
cells, cultured |
12 |
|
cervical screening |
12 |
|
china |
12 |
|
gene expression profiling |
12 |
|
hong kong |
12 |
|
mutation - genetics |
12 |
|
sensitivity and specificity |
12 |
|
brca1 protein - genetics |
11 |
|
cell adhesion molecules - genetics - metabolism |
11 |
|
cercopithecus aethiops |
11 |
|
cho cells - virology |
11 |
|
coronavirus |
11 |
|
cricetinae |
11 |
|
cricetulus |
11 |
|
endometrial carcinoma |
11 |
|
gestational trophoblastic neoplasia |
11 |
|
homozygote |
11 |
|
hydatidiform mole |
11 |
|
intestine, small - physiology |
11 |
|
lectins, c-type - genetics - metabolism |
11 |
|
lung - physiology - virology |
11 |
|
ovarian neoplasms - genetics - pathology |
11 |
|
proteasome endopeptidase complex - metabolism |
11 |
|
receptors, cell surface - genetics - metabolism |
11 |
|
rna, messenger - metabolism |
11 |
|
sars coronavirus |
11 |
|
sars virus - metabolism - pathogenicity |
11 |
|
severe acute respiratory syndrome - epidemiology - genetics |
11 |
|
species index: animalia |
11 |
|
tandem repeat sequences |
11 |
|
tumor markers, biological - analysis |
11 |
|
vero cells - virology |
11 |
|
blotting, northern |
10 |
|
breast cancer |
10 |
|
cervical cytology |
10 |
|
chinese |
10 |
|
dna mutational analysis |
10 |
|
dna, neoplasm - genetics |
10 |
|
genes, tumor suppressor |
10 |
|
medical sciences |
10 |
|
screening |
10 |
|
tissue distribution |
10 |
|
transcription, genetic |
10 |
|
amino acid sequence |
9 |
|
antibodies, viral - biosynthesis |
9 |
|
cervical intraepithelial neoplasia |
9 |
|
chemoresistance |
9 |
|
colposcopy |
9 |
|
dna, viral - genetics |
9 |
|
gene expression |
9 |
|
hydatidiform mole - genetics |
9 |
|
hysterectomy |
9 |
|
influenza a virus, h1n1 subtype - genetics - isolation and purification - physiology |
9 |
|
microsatellite repeats |
9 |
|
olfactomedin-1 |
9 |
|
orthomyxoviridae infections - immunology - mortality - physiopathology - virology |
9 |
|
ovarian neoplasms - genetics |
9 |
|
placenta - metabolism |
9 |
|
prevalence |
9 |
|
promoter regions, genetic |
9 |
|
proteins - genetics - metabolism |
9 |
|
rats |
9 |
|
spermatogenesis - physiology |
9 |
|
survival analysis |
9 |
|
t-lymphocytes - immunology |
9 |
|
tumor markers, biological - metabolism |
9 |
|
adrenomedullin |
8 |
|
asian continental ancestry group - genetics |
8 |
|
autophagy |
8 |
|
carcinoma - genetics - pathology |
8 |
|
cell differentiation |
8 |
|
cell line, transformed |
8 |
|
choriocarcinoma - genetics |
8 |
|
disease progression |
8 |
|
dna primers |
8 |
|
estrogen receptor alpha - genetics - metabolism |
8 |
|
estrogen receptors |
8 |
|
genes, p53 - genetics |
8 |
|
genotype |
8 |
|
gli1 |
8 |
|
hydatidiform mole - genetics - pathology |
8 |
|
in situ nick-end labeling |
8 |
|
incidence |
8 |
|
karyotyping |
8 |
|
ovarian neoplasms - genetics - metabolism - pathology |
8 |
|
p53 |
8 |
|
phenotype |
8 |
|
prognostic marker |
8 |
|
promoter regions, genetic - genetics |
8 |
|
risk factors |
8 |
|
signal transduction |
8 |
|
trophoblastic neoplasms - metabolism - pathology |
8 |
|
uterine neoplasms - genetics - pathology |
8 |
|
uterine neoplasms - metabolism - pathology |
8 |
|
vaginal smears |
8 |
|
acrosome - physiology |
7 |
|
antigens, neoplasm |
7 |
|
breast neoplasms - epidemiology - genetics |
7 |
|
breast neoplasms - genetics |
7 |
|
carcinoma, squamous cell - genetics |
7 |
|
cell cycle proteins - analysis |
7 |
|
cell movement |
7 |
|
cervical cancer screening |
7 |
|
cervix |
7 |
|
cervix uteri - virology |
7 |
|
chemokines |
7 |
|
chromosome aberrations |
7 |
|
chromosome in situ hybridization |
7 |
|
ciliary beat frequency |
7 |
|
cytology |
7 |
|
diagnostic biomarker |
7 |
|
disease transmission, infectious |
7 |
|
dna, mitochondrial - genetics |
7 |
|
dna-binding proteins |
7 |
|
epithelioid |
7 |
|
gene amplification |
7 |
|
gene expression regulation, neoplastic - genetics |
7 |
|
genes, brca1 |
7 |
|
genes, brca2 |
7 |
|
gestational |
7 |
|
gestational trophoblastic disease - metabolism - pathology |
7 |
|
hedgehog |
7 |
|
homeodomain proteins - genetics - metabolism |
7 |
|
hpv |
7 |
|
hydatidiform mole - metabolism - pathology |
7 |
|
iaspp |
7 |
|
immunotherapy |
7 |
|
in situ hybridization, fluorescence |
7 |
|
inflammatory cytokines |
7 |
|
ki-67 antigen - analysis |
7 |
|
ki67 |
7 |
|
leiomyosarcoma |
7 |
|
mice |
7 |
|
microrna |
7 |
|
nasal ciliated epithelium |
7 |
|
neoplasm metastasis |
7 |
|
ovarian clear cell carcinoma |
7 |
|
ovarian neoplasms - metabolism - pathology |
7 |
|
ovary - pathology |
7 |
|
papillomaviridae - isolation & purification |
7 |
|
plk1 |
7 |
|
polymorphism, genetic - genetics |
7 |
|
proliferation |
7 |
|
protein structure, tertiary |
7 |
|
repressor proteins - biosynthesis |
7 |
|
rna, messenger - analysis |
7 |
|
self-sampling |
7 |
|
sequence alignment |
7 |
|
spermatozoa - cytology - metabolism |
7 |
|
testis - cytology - physiology |
7 |
|
time factors |
7 |
|
transcription factors - genetics - metabolism |
7 |
|
trophoblastic |
7 |
|
tumor cells, cultured |
7 |
|
tumors |
7 |
|
uterus |
7 |
|
zinc fingers |
7 |
|
acrosome |
6 |
|
acrosome - metabolism |
6 |
|
adenocarcinoma - genetics - metabolism - pathology |
6 |
|
age factors |
6 |
|
animal experiment |
6 |
|
animal model |
6 |
|
asian continental ancestry group |
6 |
|
azacitidine - analogs & derivatives - pharmacology |
6 |
|
blotting, southern |
6 |
|
brca1 |
6 |
|
c-mos |
6 |
|
caspases - metabolism |
6 |
|
cell line |
6 |
|
cell nucleus - metabolism |
6 |
|
checkpoint inhibitor |
6 |
|
cin |
6 |
|
comparative genomic hybridization |
6 |
|
co‐testing |
6 |
|
cpg islands |
6 |
|
cross-sectional studies |
6 |
|
cyclin-dependent kinase inhibitor p21 |
6 |
|
e-cadherin |
6 |
|
endometrial cancer |
6 |
|
endometrial neoplasms - genetics - metabolism |
6 |
|
epigenesis, genetic |
6 |
|
epithelial cells - pathology |
6 |
|
extracellular matrix proteins - physiology |
6 |
|
fallopian tubes - cytology - metabolism |
6 |
|
genital neoplasms, female - genetics |
6 |
|
genital neoplasms, female - metabolism - pathology |
6 |
|
germ cell tumor |
6 |
|
glycoproteins - physiology |
6 |
|
golgi apparatus |
6 |
|
gynecological neoplasm |
6 |
|
hedgehog proteins - genetics - metabolism |
6 |
|
helix-loop-helix motifs |
6 |
|
hpv testing |
6 |
|
hpv16/18 genotyping |
6 |
|
id proteins |
6 |
|
immunoenzyme techniques |
6 |
|
immunoprecipitation |
6 |
|
inhibitor of differentiation protein 1 |
6 |
|
lymphadenectomy |
6 |
|
malignant ovarian germ cell tumors |
6 |
|
mapk signaling |
6 |
|
metallothionein - genetics - metabolism |
6 |
|
metallothionein 1e gene |
6 |
|
metastasis |
6 |
|
microdissection |
6 |
|
microsatellite repeats - genetics |
6 |
|
neoplasm proteins - genetics - metabolism |
6 |
|
neoplasms |
6 |
|
nuclear proteins - genetics - metabolism |
6 |
|
oligonucleotide array sequence analysis |
6 |
|
ovarian carcinoma |
6 |
|
ovary |
6 |
|
p16 |
6 |
|
p63 |
6 |
|
papillomaviridae - classification - isolation & purification |
6 |
|
papillomavirus infections - diagnosis - virology |
6 |
|
papillomavirus infections - epidemiology - ethnology - virology |
6 |
|
pax1/sox1 methylation |
6 |
|
pd-l1 |
6 |
|
placenta - chemistry |
6 |
|
placenta - metabolism - pathology |
6 |
|
ploidies |
6 |
|
pregnancy, tubal - physiopathology |
6 |
|
promoter hypermethylation |
6 |
|
prospective studies |
6 |
|
proteins - chemistry - genetics - metabolism |
6 |
|
proto-oncogene proteins c-mos - biosynthesis |
6 |
|
retrospective studies |
6 |
|
reverse transcriptase polymerase chain reaction - methods |
6 |
|
rna, neoplasm - analysis |
6 |
|
sequence analysis, dna |
6 |
|
sequence homology, amino acid |
6 |
|
sermatogenesis |
6 |
|
spectrometry, mass, matrix-assisted laser desorption-ionization |
6 |
|
spermatogenesis - genetics |
6 |
|
syntaxin |
6 |
|
testis - metabolism |
6 |
|
tomography, x-ray computed |
6 |
|
transcription factors - biosynthesis |
6 |
|
triage |
6 |
|
trophoblastic tumor, placental site - genetics - metabolism - pathology |
6 |
|
trophoblasts - chemistry - pathology |
6 |
|
tumor suppressor protein p53 - analysis |
6 |
|
tumourigenicity |
6 |
|
up-regulation |
6 |
|
uterine cervical neoplasms - genetics |
6 |
|
uterine cervical neoplasms - genetics - metabolism - pathology |
6 |
|
uterine neoplasms - genetics - metabolism - pathology |
6 |
|
wnt proteins - physiology |
6 |
|
wnt signaling |
6 |
|
wnt-signaling |
6 |
|
zic2 |
6 |
|
β-actin |
6 |
|
adaptor proteins, signal transducing - genetics |
5 |
|
adenocarcinoma, clear cell - genetics - metabolism - pathology |
5 |
|
alleles |
5 |
|
antigens, polyomavirus transforming - genetics |
5 |
|
antimetabolites, antineoplastic - pharmacology |
5 |
|
antineoplastic-agents-pharmacology |
5 |
|
apoptosis regulatory proteins |
5 |
|
apoptosis regulatory proteins - genetics - metabolism |
5 |
|
ascites |
5 |
|
biological markers - analysis |
5 |
|
biopsy, needle |
5 |
|
blotting, western - methods |
5 |
|
blu |
5 |
|
breast neoplasms - diagnosis - prevention & control |
5 |
|
c-dna array |
5 |
|
calcium-calmodulin-dependent protein kinases - genetics |
5 |
|
cancer metabolism |
5 |
|
cancer prognosis |
5 |
|
cancer stem cell |
5 |
|
carcinoma, endometrioid - enzymology - genetics |
5 |
|
carcinoma, endometrioid - enzymology - genetics - metabolism - pathology |
5 |
|
carcinoma, endometrioid - enzymology - genetics - pathology |
5 |
|
carcinoma, endometrioid - genetics - metabolism - pathology |
5 |
|
carcinoma, squamous cell - ethnology - genetics - virology |
5 |
|
carcinoma, squamous cell - genetics - virology |
5 |
|
cd55 |
5 |
|
cd8+ t cell |
5 |
|
cdna microarray |
5 |
|
cell culture techniques - methods |
5 |
|
cell cycle proteins |
5 |
|
cell cycle proteins - analysis - genetics |
5 |
|
cell invasion and proliferation |
5 |
|
cervical intra-epithelial neoplasia |
5 |
|
cervical intraepithelial neoplasia - ethnology - genetics - virology |
5 |
|
cervix uteri - chemistry - metabolism |
5 |
|
choriocarcinoma-pathology |
5 |
|
chorionic gonadotropin - blood |
5 |
|
chromosome painting |
5 |
|
clear cell |
5 |
|
confidence intervals |
5 |
|
cyclin-dependent kinase inhibitor p21 - antagonists and inhibitors - genetics |
5 |
|
cystadenocarcinoma, mucinous - genetics - metabolism - pathology |
5 |
|
cystadenocarcinoma, serous - genetics - metabolism - pathology |
5 |
|
cytogenetic analysis - methods |
5 |
|
dalys |
5 |
|
dapk |
5 |
|
dichloroacetate dca |
5 |
|
dna - analysis |
5 |
|
dna hypermethylation |
5 |
|
dna replication |
5 |
|
dna, complementary - analysis |
5 |
|
dna, neoplasm |
5 |
|
dna, neoplasm - blood |
5 |
|
dna, neoplasm - chemistry - genetics - metabolism |
5 |
|
dna, viral - analysis |
5 |
|
dna-binding proteins - analysis |
5 |
|
dnmt1 |
5 |
|
donor/recipient origin |
5 |
|
endometrial neoplasms - enzymology - genetics |
5 |
|
endometrial neoplasms - enzymology - genetics - metabolism - pathology |
5 |
|
endometrial neoplasms - enzymology - genetics - pathology |
5 |
|
endometrial neoplasms - metabolism - pathology |
5 |
|
endometrium |
5 |
|
epithelial cells - cytology - metabolism |
5 |
|
epithelial ovarian cancer |
5 |
|
evaluation studies as topic |
5 |
|
fallopian tubes - pathology |
5 |
|
follow-up studies |
5 |
|
forkhead transcription factors - analysis - genetics |
5 |
|
forkhead transcription factors - analysis - genetics - physiology |
5 |
|
foxg1 |
5 |
|
foxm1 |
5 |
|
gene expression regulation, enzymologic |
5 |
|
gene frequency |
5 |
|
genes, p16 |
5 |
|
genes, ras |
5 |
|
genes, viral - genetics |
5 |
|
genetic predisposition to disease - genetics |
5 |
|
genitalia, female - cytology |
5 |
|
genotyping |
5 |
|
gestational trophoblastic disease - genetics - metabolism - pathology |
5 |
|
gestational trophoblastic disease - genetics - pathology |
5 |
|
glutathione s-transferase pi |
5 |
|
glutathione transferase - analysis - genetics - metabolism |
5 |
|
glutathione transferase - genetics |
5 |
|
hdab2ip |
5 |
|
health care surveys |
5 |
|
hexokinase ii |
5 |
|
hpv‐e6 |
5 |
|
human papillomavirus 16 - genetics |
5 |
|
human papillomavirus 18 - genetics |
5 |
|
hydatidiform mole - diagnosis - genetics - pathology |
5 |
|
hydatidiform mole - genetics - pathology - surgery |
5 |
|
hydatidiform mole - metabolism |
5 |
|
iatrogenesis |
5 |
|
iatrogenic disease - epidemiology |
5 |
|
immunohistochemical staining |
5 |
|
in situ hybridization - methods |
5 |
|
in vitro culture |
5 |
|
intestinal mucosa - pathology |
5 |
|
intracellular signaling peptides and proteins |
5 |
|
isoenzymes - genetics |
5 |
|
keratins - metabolism |
5 |
|
ki-67 antigen - biosynthesis |
5 |
|
leiomyoma with bizarre nuclei |
5 |
|
logistic models |
5 |
|
loss of heterozygosity |
5 |
|
lymphoma, b-cell - etiology - genetics - pathology |
5 |
|
mass screening - utilization |
5 |
|
mcl-1 |
5 |
|
mcm7 |
5 |
|
metastatic partial mole |
5 |
|
methylation |
5 |
|
mgmt |
5 |
|
microsatellite analysis |
5 |
|
minichromosome maintenance protein 7 (mcm7) |
5 |
|
multivariate analysis |
5 |
|
nanog |
5 |
|
neoplasm invasiveness |
5 |
|
neoplasm recurrence, local |
5 |
|
nerve tissue proteins - analysis - genetics - physiology |
5 |
|
nuclear proteins |
5 |
|
nuclear proteins - analysis |
5 |
|
o(6)-methylguanine-dna methyltransferase - genetics |
5 |
|
odds ratio |
5 |
|
oncogenes - genetics |
5 |
|
organ transplantation - adverse effects - pathology |
5 |
|
ovarian neoplasms - drug therapy - pathology |
5 |
|
ovarian neoplasms - pathology |
5 |
|
ovary - metabolism - pathology |
5 |
|
oviduct |
5 |
|
oxidoreductases |
5 |
|
p-p53 (ser15) |
5 |
|
p21waf1/cip1 |
5 |
|
papillomaviridae |
5 |
|
papillomavirus infections - ethnology - genetics |
5 |
|
pcna |
5 |
|
pd-1 |
5 |
|
pdk1 |
5 |
|
phosphohistone-h3 |
5 |
|
placenta - anatomy & histology |
5 |
|
placental site trophoblastic tumor |
5 |
|
polymorphism, genetic |
5 |
|
polymorphism, restriction fragment length |
5 |
|
polymorphism, single nucleotide |
5 |
|
post-transplantation lymphoproliferative disorder |
5 |
|
postoperative complications - etiology - pathology |
5 |
|
precancerous conditions - ethnology - genetics - virology |
5 |
|
probability |
5 |
|
proliferating cell nuclear antigen - biosynthesis |
5 |
|
promoter cpg island hypermethylation |
5 |
|
proteins - genetics |
5 |
|
proteins - metabolism |
5 |
|
proto-oncogene proteins c-bcl-2 - genetics - metabolism |
5 |
|
public health and safety |
5 |
|
pyruvate kinase |
5 |
|
random cervical biopsy |
5 |
|
ras gtpase-activating proteins - metabolism |
5 |
|
rassf1a |
5 |
|
rassf2a |
5 |
|
repressor proteins - metabolism |
5 |
|
reproducibility of results |
5 |
|
reproduction |
5 |
|
rna, messenger - genetics - metabolism |
5 |
|
smooth muscle tumour of uncertain malignant potential |
5 |
|
squamous intraepithelial lesion |
5 |
|
statistics, nonparametric |
5 |
|
stemness |
5 |
|
t cells |
5 |
|
tgf-β |
5 |
|
tissue array analysis |
5 |
|
tissue donors |
5 |
|
tissue microarray |
5 |
|
transforming growth factor beta - pharmacology |
5 |
|
tretinoin-pharmacology |
5 |
|
tumor markers, biological - genetics |
5 |
|
tumor suppressor proteins |
5 |
|
tumor suppressor proteins - metabolism |
5 |
|
tumor virus infections - diagnosis |
5 |
|
uterine cervical neoplasms - blood - enzymology - genetics |
5 |
|
uterine cervical neoplasms - diagnosis - prevention & control |
5 |
|
uterine cervical neoplasms - ethnology - genetics - virology |
5 |
|
uterine cervical neoplasms - microbiology |
5 |
|
uterine neoplasms - diagnosis - genetics - pathology |
5 |
|
uterine neoplasms - genetics - pathology - surgery |
5 |
|
vin |
5 |
|
viral dna integration |
5 |
|
virus integration - genetics |
5 |
|
vulvar cancer |
5 |
|
vulvar dystrophy |
5 |
|
vulvar neoplasms - genetics - virology |
5 |
|
adenocarcinoma - enzymology |
4 |
|
adenocarcinoma - genetics |
4 |
|
adenocarcinoma - metabolism - pathology |
4 |
|
adenocarcinoma - pathology |
4 |
|
amp-activated protein kinases |
4 |
|
animal modelanimal tissue |
4 |
|
antibodies - pharmacology |
4 |
|
apoptosis - genetics - physiology |
4 |
|
ascites - etiology |
4 |
|
atr-chk1 |
4 |
|
autophagy and chemoresistance |
4 |
|
b-catenin |
4 |
|
bcl-2-associated x protein |
4 |
|
bd onclarity |
4 |
|
beta catenin |
4 |
|
beta catenin - metabolism |
4 |
|
brca2 protein |
4 |
|
c-33 a cell line |
4 |
|
c-4-i cell line |
4 |
|
c-erbb2 |
4 |
|
cadherin-11 |
4 |
|
cadherins - antagonists and inhibitors - genetics - physiology |
4 |
|
cadherins - biosynthesis |
4 |
|
cadherins - biosynthesis - metabolism |
4 |
|
cancer aggressiveness |
4 |
|
cancer cell |
4 |
|
cancer stem cells |
4 |
|
candidate cancer genes |
4 |
|
carcinoma |
4 |
|
carcinoma, hepatocellular - pathology - surgery |
4 |
|
carcinoma, squamous cell - diagnosis - enzymology - virology |
4 |
|
carcinoma, squamous cell - enzymology |
4 |
|
cartilage - cytology - embryology - metabolism |
4 |
|
caspases-biosynthesis |
4 |
|
catenins - genetics - metabolism - physiology |
4 |
|
catheter ablation |
4 |
|
cell cycle |
4 |
|
cell division |
4 |
|
cell division - drug effects |
4 |
|
cell invasion |
4 |
|
cell migration and invasion |
4 |
|
cell nucleus |
4 |
|
centromere |
4 |
|
cervical cancers |
4 |
|
cervical intraepithelial neoplasia - diagnosis - enzymology - pathology - virology |
4 |
|
cervical smear |
4 |
|
cervix uteri - metabolism |
4 |
|
child |
4 |
|
china - ethnology |
4 |
|
choriocarcinoma - genetics - metabolism |
4 |
|
choriocarcinoma - genetics - pathology |
4 |
|
choriocarcinoma - metabolism |
4 |
|
choriocarcinoma-enzymology |
4 |
|
chorionic gonadotropin, beta subunit, human - metabolism |
4 |
|
chromosomal proteins, non-histone - genetics |
4 |
|
chromosome |
4 |
|
chromosome deletion |
4 |
|
chromosomes, human, pair 11 |
4 |
|
chromosomes, human, pair 12 |
4 |
|
chromosomes, human, pair 16 - genetics |
4 |
|
chromosomes, human, pair 17 |
4 |
|
chromosomes, human, pair 5 |
4 |
|
chromosomes, human, pair 5 - genetics |
4 |
|
chromosomes, human, y - genetics - metabolism - ultrastructure |
4 |
|
cisplatin resistance |
4 |
|
cloning, molecular |
4 |
|
collagen - biosynthesis - classification - genetics |
4 |
|
community-based learning |
4 |
|
community-based medical education |
4 |
|
compliance |
4 |
|
concurrent methylation |
4 |
|
cytogenetic study |
4 |
|
cytogenetics |
4 |
|
cytoplasm - enzymology |
4 |
|
cytoskeletal proteins - biosynthesis |
4 |
|
dedifferentiation |
4 |
|
differential gene expression |
4 |
|
differentiation |
4 |
|
disease-free survival |
4 |
|
dna - chemistry |
4 |
|
dna modification methylases - antagonists & inhibitors |
4 |
|
dna primers - chemistry |
4 |
|
dna primers - genetics |
4 |
|
dna, complementary - metabolism |
4 |
|
dna, neoplasm - metabolism |
4 |
|
dna,-viral-isolation-and-purification |
4 |
|
dna-directed dna polymerase - genetics |
4 |
|
down-regulation |
4 |
|
drug resistance, neoplasm - genetics |
4 |
|
duoxa1 |
4 |
|
educational status |
4 |
|
electrophoresis, agar gel |
4 |
|
embryonic and fetal development - physiology |
4 |
|
endometrial cancers |
4 |
|
endometrial neoplasms - genetics |
4 |
|
endometrial neoplasms - genetics - metabolism - pathology |
4 |
|
endometrial neoplasms - genetics - pathology - ultrastructure |
4 |
|
endometrial neoplasms - pathology - physiopathology |
4 |
|
endometrial stromal sarcoma |
4 |
|
enzyme inhibitors - pharmacology |
4 |
|
epigenesis, genetic - physiology |
4 |
|
epstein-barr virus |
4 |
|
estradiol - pharmacology |
4 |
|
estrogen receptor alpha - biosynthesis - genetics |
4 |
|
estrogen receptor beta - genetics - metabolism |
4 |
|
ewing sarcoma |
4 |
|
exons |
4 |
|
extravillous trophoblast |
4 |
|
eye proteins - antagonists & inhibitors - genetics - pharmacology |
4 |
|
fak/erk signaling |
4 |
|
fatal outcome |
4 |
|
fetus - metabolism |
4 |
|
filter‐in‐situ hybridization |
4 |
|
first-trimester |
4 |
|
follistatin-related proteins - genetics - physiology |
4 |
|
founder effect |
4 |
|
gadolinium dtpa - diagnostic use |
4 |
|
gene dosage |
4 |
|
gene expression - drug effects |
4 |
|
gene expression profiling - methods |
4 |
|
gene expression regulation, developmental |
4 |
|
gene expression regulation, neoplastic - drug effects |
4 |
|
gene-expression-regulation,-neoplastic |
4 |
|
genes, homeobox |
4 |
|
genes, p53 |
4 |
|
genetic markers |
4 |
|
genetics, population |
4 |
|
genome, human |
4 |
|
genomic instability - genetics |
4 |
|
germ-line mutation - genetics |
4 |
|
gestational trophoblastic disease - genetics |
4 |
|
gestational trophoblastic diseases |
4 |
|
gestational trophoblastic neoplasms - genetics - pathology - therapy |
4 |
|
gnrh |
4 |
|
gpi-linked proteins |
4 |
|
gtp-binding proteins - metabolism |
4 |
|
gynecological cancer |
4 |
|
gynecological cancers |
4 |
|
health knowledge, attitudes, practice |
4 |
|
health surveys |
4 |
|
hedgehog proteins - metabolism |
4 |
|
hela cells |
4 |
|
hepatitis c - complications |
4 |
|
hepatitis c virus |
4 |
|
hepatocellular carcinoma |
4 |
|
herpesvirus 4, human - isolation & purification |
4 |
|
herpesvirus-4,-human-isolation-and-purification |
4 |
|
high throughput screen |
4 |
|
high-grade squamous intraepithelial lesions |
4 |
|
hk2 |
4 |
|
hoxb5 |
4 |
|
hpv vaccine |
4 |
|
hpv vaccine perception |
4 |
|
hpv vaccine questionnaire |
4 |
|
hpv vaccine survey |
4 |
|
human embryonic gut |
4 |
|
human papilloma virus (hpv) |
4 |
|
human papillomavirus infection (hpv‐1) |
4 |
|
hydatidiform mole - genetics - metabolism - pathology |
4 |
|
hydatidiform-mole-chemistry |
4 |
|
hydroxamic acids - pharmacology |
4 |
|
igf-1r |
4 |
|
igfbp3 |
4 |
|
immunocompromised patient |
4 |
|
immunoglobulin light chains - analysis |
4 |
|
infertility, male - genetics - metabolism - pathology |
4 |
|
interphase |
4 |
|
intestinal neoplasms - pathology - radiography |
4 |
|
intestine, small - pathology - radiography |
4 |
|
intestines - embryology - metabolism |
4 |
|
isothermal amplification |
4 |
|
keratin-7 |
4 |
|
kidney transplantation - adverse effects |
4 |
|
laparoscopy |
4 |
|
leiomyoma |
4 |
|
linitis plastica - complications - diagnosis |
4 |
|
liver cell carcinoma |
4 |
|
liver neoplasms - pathology - surgery |
4 |
|
low-grade squamous intraepithelial lesions |
4 |
|
lymphoma |
4 |
|
lymphoma, b-cell - chemistry - etiology - genetics |
4 |
|
magnetic resonance imaging |
4 |
|
mass screening - methods |
4 |
|
mdm2 |
4 |
|
membrane glycoproteins - genetics - metabolism |
4 |
|
mesoderm |
4 |
|
methylation profile |
4 |
|
microsatellite instability analysis |
4 |
|
microwave coagulation |
4 |
|
microwaves - therapeutic use |
4 |
|
migration |
4 |
|
mismatch repair deficiency |
4 |
|
mitochondrial dna |
4 |
|
mitochondrial microsatellite instability |
4 |
|
models, biological |
4 |
|
molecular diagnostic techniques - methods |
4 |
|
motility |
4 |
|
multienzyme complexes - genetics |
4 |
|
neoplasm proteins - analysis |
4 |
|
neoplasm proteins - genetics |
4 |
|
neoplasm proteins - metabolism |
4 |
|
neoplastic stem cells - physiology |
4 |
|
nerve growth factors - antagonists & inhibitors - genetics - pharmacology |
4 |
|
neural crest - cytology - embryology |
4 |
|
neural crest cels |
4 |
|
neurons - cytology - metabolism |
4 |
|
normal and pathological pregnancies |
4 |
|
notch |
4 |
|
nuclear proteins - genetics |
4 |
|
nuclear receptor co-repressor 2 - genetics |
4 |
|
nurr1 |
4 |
|
obstetrics and gynecology medical sciences |
4 |
|
oct4 |
4 |
|
octamer transcription factor-3 - genetics - metabolism |
4 |
|
oncogene proteins, viral - biosynthesis |
4 |
|
oncology |
4 |
|
osteopontin |
4 |
|
ovarian neoplasms - enzymology - genetics - pathology |
4 |
|
ovarian neoplasms - genetics - metabolism |
4 |
|
ovarian neoplasms - pathology - physiopathology |
4 |
|
ovarian tumors |
4 |
|
ovary - cytology - metabolism |
4 |
|
ovary - metabolism |
4 |
|
p-cadherin |
4 |
|
p120ctn |
4 |
|
p21-activated kinases - antagonists and inhibitors - genetics - physiology |
4 |
|
pak1 |
4 |
|
pak2 |
4 |
|
papillomaviridae - classification - genetics - isolation and purification |
4 |
|
papillomaviridae - genetics |
4 |
|
papillomaviridae - immunology |
4 |
|
papillomavirus e7 proteins |
4 |
|
papillomavirus infections - complications - enzymology - genetics |
4 |
|
papillomavirus infections - prevention & control - virology |
4 |
|
papillomavirus vaccines |
4 |
|
pelvis - pathology |
4 |
|
phosphorylation |
4 |
|
pilot projects |
4 |
|
placenta |
4 |
|
placenta - cytology |
4 |
|
placenta - physiology |
4 |
|
placenta accreta - metabolism - pathology |
4 |
|
placenta-chemistry |
4 |
|
placental site |
4 |
|
placental-site tro phoblastic tumor |
4 |
|
plasmids |
4 |
|
polymerase chain reaction - methods |
4 |
|
post- transplantation |
4 |
|
pre-eclampsia - metabolism - pathology |
4 |
|
prediction model |
4 |
|
predictive value of tests |
4 |
|
pregnancy complications, infectious - diagnosis - enzymology - virology |
4 |
|
pregnancy complications, infectious - epidemiology - pathology |
4 |
|
pregnancy complications, neoplastic - pathology |
4 |
|
pregnancy trimester, first |
4 |
|
pregnancy trimester, third - genetics |
4 |
|
pregnancy trimesters |
4 |
|
primary care |
4 |
|
primitive neuroectodermal tumor |
4 |
|
prkaa1 |
4 |
|
promoter regions (genetics) |
4 |
|
prostate stem cell antigen |
4 |
|
prostatic neoplasms - genetics - metabolism - pathology |
4 |
|
protein-serine-threonine kinases - genetics |
4 |
|
proto-oncogene proteins c-bcl-2 - metabolism |
4 |
|
proto-oncogene-proteins-c-myc-analysis |
4 |
|
quality assurance |
4 |
|
quality criteria |
4 |
|
questionnaires |
4 |
|
radiation tolerance - genetics |
4 |
|
radio waves |
4 |
|
radiofrequency ablation |
4 |
|
radioresistance |
4 |
|
receptor, erbb-2 - metabolism |
4 |
|
receptor, igf type 1 - antagonists and inhibitors - genetics - physiology |
4 |
|
receptor,-macrophage-colony-stimulating-factor-analysis |
4 |
|
receptors, cell surface - metabolism |
4 |
|
receptors, fsh - genetics |
4 |
|
recurrence of hcc |
4 |
|
rho gtp-binding proteins - metabolism |
4 |
|
rna - isolation & purification |
4 |
|
rna - metabolism |
4 |
|
rna, messenger - biosynthesis - genetics |
4 |
|
rna, messenger - biosynthesis - metabolism |
4 |
|
rna, small interfering - pharmacology |
4 |
|
rna, viral - analysis |
4 |
|
rna-binding proteins - genetics - metabolism |
4 |
|
ros |
4 |
|
sarcoma, endometrial stromal - genetics - pathology - ultrastructure |
4 |
|
sarcoma, ewing - pathology - radiography |
4 |
|
self-renewal |
4 |
|
semi-quantitative fluorescent differential pcr |
4 |
|
sentis hpv |
4 |
|
serpins - genetics - pharmacology |
4 |
|
sialoglycoproteins - metabolism |
4 |
|
signal transduction - genetics |
4 |
|
signal transduction - physiology |
4 |
|
small intestine |
4 |
|
somatic mutations |
4 |
|
spain - epidemiology |
4 |
|
sperm |
4 |
|
spermatogenesis |
4 |
|
spermatozoa - metabolism - pathology - ultrastructure |
4 |
|
stat3 |
4 |
|
stat3 transcription factor - biosynthesis - genetics - metabolism |
4 |
|
stomach neoplasms - complications - diagnosis |
4 |
|
sulfites - chemistry |
4 |
|
suppression subtractive hybridization |
4 |
|
survival |
4 |
|
survival rate |
4 |
|
telomerase |
4 |
|
telomerase - analysis |
4 |
|
telomerase - metabolism |
4 |
|
telomerase repeat amplification protocol |
4 |
|
telomere - enzymology - genetics |
4 |
|
temperature |
4 |
|
testis |
4 |
|
testis - metabolism - pathology |
4 |
|
tgfβ |
4 |
|
therapeutic molecular target |
4 |
|
therapeutic target |
4 |
|
trans-activators - biosynthesis |
4 |
|
transcription factors - genetics |
4 |
|
transcription factors - metabolism |
4 |
|
transforming growth factor beta - physiology |
4 |
|
transforming growth factor beta1 |
4 |
|
trf |
4 |
|
trophoblastic tissue |
4 |
|
trophoblastic tumor |
4 |
|
trophoblasts - metabolism - pathology |
4 |
|
trophoblasts - physiology |
4 |
|
trophoblasts-chemistry |
4 |
|
tumor markers, biological - genetics - metabolism |
4 |
|
tumor suppressor genes |
4 |
|
tumor suppressor protein p53 - genetics - metabolism |
4 |
|
tumor virus infections - epidemiology - pathology |
4 |
|
uterine cervical diseases - microbiology |
4 |
|
uterine cervical dysplasia - diagnosis - enzymology - pathology - virology |
4 |
|
uterine cervical neoplasms - diagnosis - enzymology - pathology - virology |
4 |
|
uterine cervical neoplasms - enzymology |
4 |
|
uterine cervical neoplasms - enzymology - genetics - virology |
4 |
|
uterine cervical neoplasms - metabolism - radiotherapy |
4 |
|
uterine cervical neoplasms - prevention & control - virology |
4 |
|
uterine cervicitis - enzymology - pathology - virology |
4 |
|
uterine cervix |
4 |
|
uterine leiomyosarcoma |
4 |
|
uterine neoplasms |
4 |
|
uterine neoplasms - genetics - metabolism |
4 |
|
uterine-neoplasms-enzymology |
4 |
|
vagus nerve - cytology - embryology |
4 |
|
venous thromboembolism |
4 |
|
vulvar-neoplasms-microbiology |
4 |
|
x chromosome |
4 |
|
y chromosome |
4 |
|
young adult |
4 |
|
β-catenin |
4 |
|
18-carcinoma of the cervix |
3 |
|
3d spheroid based drug sensitivity assay |
3 |
|
abdominal hysterectomy |
3 |
|
abdominal neoplasms - chemistry - pathology |
3 |
|
abortion, spontaneous |
3 |
|
abortion, spontaneous - immunology |
3 |
|
abortion, spontaneous - metabolism |
3 |
|
acrosome reaction |
3 |
|
acrosome reaction - drug effects |
3 |
|
actin |
3 |
|
actins - metabolism - ultrastructure |
3 |
|
adaptor proteins, signal transducing - genetics - metabolism |
3 |
|
adenocarcinoma |
3 |
|
adenocarcinoma - diagnosis - pathology |
3 |
|
adenocarcinoma, clear cell - genetics - pathology |
3 |
|
adenocarcinoma, mucinous - diagnosis - pathology - therapy - ultrastructure |
3 |
|
adjuvants |
3 |
|
adrenomedullin - blood - genetics - physiology |
3 |
|
ais |
3 |
|
alphapapillomavirus - isolation and purification |
3 |
|
animal cell |
3 |
|
antifibrinolytic agents - adverse effects |
3 |
|
antigens, neoplasm - metabolism |
3 |
|
antineoplastic agents, phytogenic - pharmacology |
3 |
|
anxiety - etiology |
3 |
|
apoferritins |
3 |
|
apoptosis - physiology |
3 |
|
apoptotic (ai) and mitotic indices (mi) |
3 |
|
apoptotic activity |
3 |
|
arias-stella reactionclear |
3 |
|
asia |
3 |
|
asian continental ancestry group - ethnology |
3 |
|
asian screening population |
3 |
|
asian women |
3 |
|
aspp1 |
3 |
|
attitude to health |
3 |
|
atypical cytology |
3 |
|
atypical leiomyoma |
3 |
|
atypical squamous cells of undetermined significance |
3 |
|
autophagy (cellular) |
3 |
|
beliefs |
3 |
|
bioassay |
3 |
|
biological markers - blood |
3 |
|
brain-derived neurotrophic factor - biosynthesis |
3 |
|
breast neoplasms - ethnology - genetics |
3 |
|
brenner tumor - diagnosis - metabolism - pathology |
3 |
|
brenner tumour |
3 |
|
c-erbb-2 |
3 |
|
c-fms |
3 |
|
c-kit |
3 |
|
c-myc |
3 |
|
cancer radiotherapy |
3 |
|
cancer screening |
3 |
|
carcinogenesis |
3 |
|
carcinoid tumor - diagnosis - pathology - therapy - ultrastructure |
3 |
|
carcinoma - complications - mortality |
3 |
|
carcinoma - enzymology - mortality - pathology |
3 |
|
carcinoma in situ - pathology |
3 |
|
carcinoma of cervix |
3 |
|
carcinoma, endometrioid - chemistry - pathology |
3 |
|
carcinoma, non-small-cell lung - genetics - metabolism - pathology |
3 |
|
carcinoma, squamous cell - diagnosis - genetics |
3 |
|
carcinoma, squamous cell - metabolism - mortality - virology |
3 |
|
carcinoma, squamous cell - pathology |
3 |
|
carcinoma, squamous cell - pathology - radiotherapy - surgery |
3 |
|
carcinoma, transitional cell - diagnosis - metabolism - pathology |
3 |
|
caspase |
3 |
|
cathepsin d |
3 |
|
cathepsin d - chemistry |
3 |
|
cdc42 |
3 |
|
cell carcinoma |
3 |
|
cell migration |
3 |
|
cell movement - genetics |
3 |
|
cell movement - physiology |
3 |
|
cervical carcinoma and prognosis |
3 |
|
cervical intraepithelial neoplasia - diagnosis |
3 |
|
cervical intraepithelial neoplasia - diagnosis - pathology |
3 |
|
cervical intraepithelial neoplasia - genetics - metabolism |
3 |
|
cervix uteri - microbiology |
3 |
|
cervix uteri - pathology |
3 |
|
cervix uteri - pathology - radiation effects |
3 |
|
cervix uteri - pathology - virology |
3 |
|
cftr |
3 |
|
child, preschool |
3 |
|
china - epidemiology |
3 |
|
chinese women |
3 |
|
choriocarcinoma - complications - surgery |
3 |
|
choriocarcinoma - diagnosis - immunology |
3 |
|
choriocarcinoma - genetics - metabolism - pathology |
3 |
|
choriocarcinomas |
3 |
|
chromosomes, human, pair 1 |
3 |
|
chromosomes, human, pair 11 - genetics |
3 |
|
chromosomes, human, pair 17 - genetics |
3 |
|
chromosomes, human, pair 4 |
3 |
|
chronic inflammation |
3 |
|
cilia - physiology |
3 |
|
cish |
3 |
|
clinical |
3 |
|
cobas |
3 |
|
combination treatment |
3 |
|
combined modality therapy |
3 |
|
comparative genomic hybridisation |
3 |
|
conditioned medium |
3 |
|
copy number |
3 |
|
culture media, conditioned - pharmacology |
3 |
|
cyclins - metabolism |
3 |
|
cystadenocarcinoma, mucinous - genetics - pathology |
3 |
|
cystadenocarcinoma, serous - chemistry - pathology |
3 |
|
cystadenocarcinoma, serous - genetics - pathology |
3 |
|
cystadenoma - enzymology - mortality - pathology |
3 |
|
cystadenoma, mucinous - chemistry - pathology |
3 |
|
cystadenoma, serous - chemistry - pathology |
3 |
|
cystic fibrosis transmembrane conductance regulator - genetics - immunology - metabolism |
3 |
|
cytogenetic analysis |
3 |
|
cytoskeleton - metabolism - ultrastructure |
3 |
|
d-loop |
3 |
|
desmin - analysis |
3 |
|
desmoplastic reaction |
3 |
|
dinucleotide repeats |
3 |
|
dj-1 |
3 |
|
dna |
3 |
|
dna amplification |
3 |
|
dna probes, hpv |
3 |
|
dna replication - genetics |
3 |
|
dna topoisomerases, type ii - analysis |
3 |
|
dna, complementary - genetics |
3 |
|
dna, mitochondrial - blood - genetics |
3 |
|
dna, mitochondrial - genetics - isolation & purification - metabolism |
3 |
|
dna, mitochondrial - genetics - metabolism |
3 |
|
dna, neoplasm - blood - genetics |
3 |
|
dna, viral - isolation & purification |
3 |
|
dna-binding proteins - biosynthesis - genetics |
3 |
|
dna-binding proteins - genetics - metabolism |
3 |
|
dock180 expression |
3 |
|
drug resistance, neoplasm |
3 |
|
e2 binding sites methylation |
3 |
|
early infarct |
3 |
|
ebv |
3 |
|
egfr |
3 |
|
embryo development |
3 |
|
embryonic and fetal development - drug effects |
3 |
|
endometrial neoplasms - genetics - pathology |
3 |
|
endometrial neoplasms - virology |
3 |
|
endometrial polyps |
3 |
|
enzymes - genetics |
3 |
|
epidermal growth factor receptor |
3 |
|
epithelial cells - metabolism - pathology |
3 |
|
epithelial cells - ultrastructure |
3 |
|
epithelial damage |
3 |
|
epithelioid cells - drug effects - pathology |
3 |
|
fallopian tube diseases - complications - genetics - pathology |
3 |
|
fallopian tube diseases - complications - pathology |
3 |
|
fallopian tube diseases - pathology |
3 |
|
fallopian tube neoplasms - pathology |
3 |
|
fallopian tubes - physiology |
3 |
|
female reproductive tract |
3 |
|
ferritins |
3 |
|
filter in situ hybridization |
3 |
|
filter in-situ-hybridization |
3 |
|
ftl |
3 |
|
gastric adenocarcinoma |
3 |
|
gene deletion |
3 |
|
gene expression regulation |
3 |
|
gene expression regulation, neoplastic - radiation effects |
3 |
|
gene knockdown techniques |
3 |
|
genes, erbb-2 |
3 |
|
germ cell tumors |
3 |
|
globins - genetics |
3 |
|
gynecologic oncology |
3 |
|
hepatoblastoma - genetics - pathology |
3 |
|
herpesvirus 4, human - genetics |
3 |
|
hnf-1β |
3 |
|
hormone receptors |
3 |
|
hpv infection |
3 |
|
hpv test |
3 |
|
hpv vaccination |
3 |
|
hpv-16 |
3 |
|
human papillomavirus (hpv) 16 |
3 |
|
human papillomavirus (hpv) 18 |
3 |
|
human papillomavirus 16 |
3 |
|
human papillomavirus 18 |
3 |
|
human papillomavirus typing |
3 |
|
hydatidiform mole - blood - complications - drug therapy - surgery |
3 |
|
hydatidiform mole - diagnosis - immunology |
3 |
|
hydatidiform mole - enzymology |
3 |
|
hydatidiform mole - genetics - metabolism |
3 |
|
hydatidiform mole - immunology - pathology |
3 |
|
hydrosalpinx |
3 |
|
hydrosalpinx fluid |
3 |
|
hypermethylation |
3 |
|
igfbp1 |
3 |
|
immunologic |
3 |
|
individuality |
3 |
|
infant |
3 |
|
infarction - chemically induced - pathology |
3 |
|
infertility |
3 |
|
infertility, female - etiology - pathology |
3 |
|
infertility, female - genetics - pathology |
3 |
|
inhibitor of apoptotic protein (iap) |
3 |
|
insulin-like growth factor binding protein 1 - genetics |
3 |
|
intermediate filament proteins - metabolism |
3 |
|
intracellular signaling peptides and proteins - genetics |
3 |
|
invasion |
3 |
|
irradiation |
3 |
|
isoenzymes - genetics - metabolism |
3 |
|
isoleucine - genetics |
3 |
|
keratin-20 |
3 |
|
keywords |
3 |
|
ki-67 antigen |
3 |
|
ki-67 index |
3 |
|
knowledge |
3 |
|
laparoscopy - methods |
3 |
|
laser capture microdissection |
3 |
|
leiomyoma - complications - drug therapy - pathology |
3 |
|
liquid-based cervical cytology |
3 |
|
liver neoplasms - genetics - pathology |
3 |
|
lung neoplasms - genetics - metabolism - pathology |
3 |
|
lung neoplasms - secondary |
3 |
|
lymphocytes - metabolism |
3 |
|
m30 |
3 |
|
mass screening |
3 |
|
matrix metalloproteinase 14 - genetics - metabolism |
3 |
|
medical sciences biology |
3 |
|
membrane glycoproteins - analysis |
3 |
|
membrane proteins - biosynthesis |
3 |
|
membrane proteins - biosynthesis - genetics |
3 |
|
membrane proteins - genetics - metabolism |
3 |
|
menorrhagia |
3 |
|
menorrhagia - drug therapy - etiology - pathology |
3 |
|
mesoderm - metabolism - pathology |
3 |
|
mi/ai ratio |
3 |
|
mice - embryology |
3 |
|
mice, inbred icr |
3 |
|
microsatellite instability |
3 |
|
microscopy |
3 |
|
microscopy, confocal |
3 |
|
microscopy, electron |
3 |
|
microscopy, electron, scanning |
3 |
|
mitochondria - genetics |
3 |
|
mitosis - drug effects |
3 |
|
mitotic index |
3 |
|
molecular epidemiology |
3 |
|
mucin |
3 |
|
mucin-1 |
3 |
|
mucins - secretion |
3 |
|
mullerian duct |
3 |
|
napsin a |
3 |
|
necrosis |
3 |
|
neoplasm grading |
3 |
|
neoplasm invasiveness - genetics - pathology |
3 |
|
neoplasm proteins - analysis - immunology |
3 |
|
neoplasm proteins/genetics |
3 |
|
neoplasm recurrence, local - pathology |
3 |
|
neoplasms, multiple primary - diagnosis - pathology - therapy - ultrastructure |
3 |
|
neoplasms, nerve tissue - chemistry - pathology |
3 |
|
neovascularization, pathologic - genetics - metabolism |
3 |
|
neuroendocrine and mucinous carcinoma |
3 |
|
non-small cell lung cancer |
3 |
|
normal cervix |
3 |
|
nuclear proteins - biosynthesis - genetics |
3 |
|
nuclear proteins - immunology - metabolism |
3 |
|
nucleic acid hybridization |
3 |
|
obstetrics and gynecology |
3 |
|
oligonucleotide array sequence analysis - methods |
3 |
|
onclarity |
3 |
|
oncogene proteins - biosynthesis - genetics |
3 |
|
ovarian neoplasms - chemistry - pathology |
3 |
|
ovarian neoplasms - diagnosis - metabolism - pathology |
3 |
|
ovarian neoplasms - diagnosis - pathology - therapy - ultrastructure |
3 |
|
ovarian neoplasms - drug therapy - metabolism - pathology |
3 |
|
ovarian neoplasms - enzymology - mortality - pathology |
3 |
|
ovarian neoplasms - enzymology - pathology |
3 |
|
ovarian neoplasms - ethnology - genetics |
3 |
|
ovarian neoplasms - metabolism - mortality - pathology |
3 |
|
ovarian neoplasms - virology |
3 |
|
ovarian tumor |
3 |
|
ovarian tumours |
3 |
|
p21(waf1/cip1) |
3 |
|
p21-activated kinases - antagonists and inhibitors - genetics - metabolism |
3 |
|
p21-activated kinases - genetics - metabolism |
3 |
|
p70 s6 kinase |
3 |
|
p73 |
3 |
|
paclitaxel - pharmacology |
3 |
|
pan-ras |
3 |
|
papillomaviridae - genetics - isolation & purification |
3 |
|
papillomavirus infections - complications - epidemiology - virology |
3 |
|
papillomavirus infections - diagnosis - psychology |
3 |
|
papillomavirus infections - ethnology - prevention & control |
3 |
|
papillomavirus infections - ethnology - prevention & control - psychology |
3 |
|
papillomavirus vaccines - therapeutic use |
3 |
|
pathology |
3 |
|
patient acceptance of health care |
3 |
|
patient acceptance of health care - ethnology |
3 |
|
patient satisfaction - ethnology |
3 |
|
pcr |
3 |
|
peptides - genetics |
3 |
|
phosphopyruvate hydratase - analysis |
3 |
|
pipelle endometrial sampler |
3 |
|
placenta - cytology - metabolism - pathology |
3 |
|
placenta - enzymology |
3 |
|
placenta - immunology - pathology |
3 |
|
poor prognosis |
3 |
|
precancerous conditions - diagnosis - genetics |
3 |
|
pregnancy complications - metabolism - pathology |
3 |
|
pregnancy complications, neoplastic - diagnosis - epidemiology - microbiology |
3 |
|
pregnancy complications, neoplastic - genetics |
3 |
|
pregnancy outcome |
3 |
|
pregnancy, tubal - blood - etiology - physiopathology |
3 |
|
prevention |
3 |
|
primary screening |
3 |
|
prognostic factor |
3 |
|
proliferating cell nuclear antigen |
3 |
|
proto-oncogenes - physiology |
3 |
|
psychology |
3 |
|
pten |
3 |
|
pten phosphohydrolase - biosynthesis - genetics |
3 |
|
rac gtp-binding proteins - analysis - biosynthesis |
3 |
|
rac1 |
3 |
|
real-time polymerase chain reaction |
3 |
|
real-time quantitative pcr |
3 |
|
receptor, epidermal growth factor - metabolism |
3 |
|
receptor, trkb - biosynthesis |
3 |
|
receptors, estrogen - chemistry |
3 |
|
receptors, progesterone - chemistry |
3 |
|
reference values |
3 |
|
repressor proteins - biosynthesis - genetics |
3 |
|
ribonuclease protection assay |
3 |
|
ribosomal protein s6 kinases, 70-kda - genetics - metabolism |
3 |
|
ribosomal protein s6 kinases, 70-kda - physiology |
3 |
|
risk |
3 |
|
risk assessment |
3 |
|
rna, ribosomal - genetics |
3 |
|
rna, ribosomal, 16s - genetics |
3 |
|
rna, small interfering |
3 |
|
sarcoma, endometrial stromal - genetics - pathology |
3 |
|
sex factors |
3 |
|
small round‐cell tumour |
3 |
|
smooth muscle tumor |
3 |
|
social hygiene clinic |
3 |
|
sox2 |
3 |
|
soxb1 transcription factors - genetics - metabolism |
3 |
|
sperm motility |
3 |
|
sperm motility - drug effects |
3 |
|
squamous cell carcinoma |
3 |
|
stomach neoplasms - pathology |
3 |
|
stress, psychological - etiology |
3 |
|
stump |
3 |
|
swabbed cervical cells |
3 |
|
targeted therapy |
3 |
|
telomerase activity |
3 |
|
terminal deoxynucleotidyl transferase (tdt)-mediated deoxyuracil triphosphate (dutp) nick-end labelling (tunel) |
3 |
|
thrombosis - chemically induced - pathology |
3 |
|
timp3 |
3 |
|
tissue array |
3 |
|
tp53 |
3 |
|
tranexamic acid |
3 |
|
tranexamic acid - adverse effects |
3 |
|
transfection |
3 |
|
transition |
3 |
|
transitional cell carcinoma |
3 |
|
trkb |
3 |
|
trophoblastic disease |
3 |
|
trophoblastic neoplasms - complications - drug therapy - surgery |
3 |
|
trophoblastic neoplasms - diagnosis - immunology |
3 |
|
trophoblastic neoplasms - genetics |
3 |
|
trophoblastic tumor, placental site - genetics - pathology |
3 |
|
trophoblastic tumor, placental site - metabolism - pathology |
3 |
|
trophoblasts - metabolism - physiology |
3 |
|
tumor suppressor protein p53 - metabolism |
3 |
|
tumor virus infections - diagnosis - epidemiology - microbiology |
3 |
|
tumor virus infections - epidemiology |
3 |
|
tumor virus infections - mortality |
3 |
|
uterine cervical diseases - epidemiology |
3 |
|
uterine cervical neoplasms |
3 |
|
uterine cervical neoplasms - complications - mortality |
3 |
|
uterine cervical neoplasms - diagnosis |
3 |
|
uterine cervical neoplasms - diagnosis - epidemiology - microbiology |
3 |
|
uterine cervical neoplasms - diagnosis - genetics |
3 |
|
uterine cervical neoplasms - diagnosis - pathology |
3 |
|
uterine cervical neoplasms - ethnology - virology |
3 |
|
uterine cervical neoplasms - genetics - metabolism |
3 |
|
uterine cervical neoplasms - genetics - mortality - pathology - radiotherapy |
3 |
|
uterine cervical neoplasms - metabolism - mortality - virology |
3 |
|
uterine cervical neoplasms - pathology |
3 |
|
uterine cervical neoplasms - pathology - radiotherapy - surgery |
3 |
|
uterine cervical neoplasms - prevention and control - virology |
3 |
|
uterine cervical neoplasms - psychology |
3 |
|
uterine cervical neoplasms - virology |
3 |
|
uterine cervix cancer |
3 |
|
uterine neoplasms - blood - complications - drug therapy - surgery |
3 |
|
uterine neoplasms - complications - drug therapy - pathology |
3 |
|
uterine neoplasms - diagnosis - immunology |
3 |
|
uterine neoplasms - genetics |
3 |
|
uterine neoplasms - pathology |
3 |
|
vaginal intraepithelial neoplasia |
3 |
|
valine - genetics |
3 |
|
vimentin - analysis |
3 |
|
viral load |
3 |
|
women's health issues |
3 |
|
young age group |
3 |
|
young. |
3 |
|
"favor neoplasia" |
2 |
|
"nos" |
2 |
|
'favor neoplasia' |
2 |
|
'nos' |
2 |
|
abortifacient agents, steroidal - pharmacology |
2 |
|
acquired immunodeficiency syndrome |
2 |
|
adenocarcinoma - blood - pathology |
2 |
|
adenocarcinoma - diagnosis - pathology - physiopathology |
2 |
|
adenocarcinoma - etiology - metabolism |
2 |
|
adenocarcinoma - secondary |
2 |
|
adenocarcinoma - virology |
2 |
|
adenocarcinoma of cervix |
2 |
|
adrenal cortex - pathology |
2 |
|
agc |
2 |
|
agus |
2 |
|
akt signaling |
2 |
|
analysis of variance |
2 |
|
androgen receptor antagonists |
2 |
|
anemia - complications |
2 |
|
anemias |
2 |
|
animal tissue |
2 |
|
antibiotics, antineoplastic - therapeutic use |
2 |
|
antibodies, monoclonal |
2 |
|
antigens, cd - analysis |
2 |
|
antigens, differentiation, myelomonocytic - analysis |
2 |
|
antigens, neoplasm - blood |
2 |
|
antineoplastic activity |
2 |
|
antineoplastic agents - pharmacology |
2 |
|
antioxidant activity |
2 |
|
aptima hpv |
2 |
|
ascitic fluid - chemistry - pathology |
2 |
|
asia - epidemiology |
2 |
|
asia pacific |
2 |
|
assisted reproduction |
2 |
|
atrx |
2 |
|
automated dna-image-cytometry |
2 |
|
bar |
2 |
|
bcl-2 |
2 |
|
bdnf |
2 |
|
biopsy - statistics & numerical data |
2 |
|
brain - pathology |
2 |
|
brain-derived neurotrophic factor - antagonists & inhibitors |
2 |
|
brca |
2 |
|
ca 125 |
2 |
|
ca-125 antigen - blood |
2 |
|
capsid proteins |
2 |
|
carcinoembryonic antigen |
2 |
|
carcinoembryonic antigen - blood |
2 |
|
carcinoid tumor - genetics |
2 |
|
carcinoma in situ - diagnosis - epidemiology - etiology - pathology |
2 |
|
carcinoma in situ - diagnosis - pathology |
2 |
|
carcinoma of the cervix |
2 |
|
carcinoma, adenosquamous - diagnosis - pathology - physiopathology |
2 |
|
carcinoma, endometrioid - pathology |
2 |
|
carcinoma, papillary - genetics |
2 |
|
carcinoma, small cell - genetics - pathology |
2 |
|
carcinoma, squamous cell - diagnosis - pathology |
2 |
|
carcinoma, squamous cell - diagnosis - pathology - physiopathology |
2 |
|
carcinoma, squamous cell - epidemiology - prevention & control - virology |
2 |
|
cardiotocography |
2 |
|
cell nucleus - pathology |
2 |
|
cell transformation, neoplastic - genetics |
2 |
|
central nervous system diseases - drug therapy |
2 |
|
cervical intraepithelial neoplasia - diagnosis - epidemiology - etiology - pathology |
2 |
|
cervical intraepithelial neoplasia - prevention & control - virology |
2 |
|
cesarean section |
2 |
|
chemotherapy, adjuvant - methods |
2 |
|
chi-square distribution |
2 |
|
cholestasis - etiology |
2 |
|
chorion |
2 |
|
chorionic gonadotropin - analysis |
2 |
|
chromosomes, human, pair 10 |
2 |
|
chromosomes, human, pair 16 |
2 |
|
chromosomes, human, pair 3 - genetics |
2 |
|
clinical trials as topic |
2 |
|
cobas hpv |
2 |
|
collision tumor |
2 |
|
combined modality therapy - methods |
2 |
|
comparison |
2 |
|
consensus sequence |
2 |
|
conventional smear |
2 |
|
cost |
2 |
|
cyclin-dependent kinase inhibitor p16 - biosynthesis |
2 |
|
cystadenocarcinoma - radiography - secondary - ultrasonography |
2 |
|
cystadenocarcinoma, mucinous - metabolism - pathology |
2 |
|
cystadenoma - ultrasonography |
2 |
|
cytomegalovirus infections - complications - diagnosis - epidemiology |
2 |
|
daxx |
2 |
|
death, sudden - etiology - pathology |
2 |
|
decidua - metabolism |
2 |
|
dermoid cyst |
2 |
|
desmin - analysis - immunology |
2 |
|
dna ploidy |
2 |
|
dna, viral - analysis - genetics |
2 |
|
double-blind method |
2 |
|
ectopic pregnancy |
2 |
|
endometrial and ovarian carcinomas |
2 |
|
endometrial hyperplasia - diagnosis - pathology |
2 |
|
endometrioid |
2 |
|
endometrioid carcinoma |
2 |
|
endometrioid with clear cells |
2 |
|
epidemiology |
2 |
|
epirubicin - therapeutic use |
2 |
|
epithelioid leiomyosarcoma |
2 |
|
exaggerated placental site |
2 |
|
female genital tract |
2 |
|
follicle stimulating hormone - pharmacology - physiology |
2 |
|
gastric lymphoma |
2 |
|
gastritis - genetics - pathology |
2 |
|
gastrointestinal diseases - diagnosis - epidemiology - microbiology |
2 |
|
gastrointestinal hemorrhage - etiology |
2 |
|
gene expression regulation, neoplastic - physiology |
2 |
|
genes, bcl-2 |
2 |
|
genital neoplasms, female - complications |
2 |
|
genital neoplasms, female - diagnosis - pathology |
2 |
|
genital neoplasms, female - pathology |
2 |
|
genomic imprinting |
2 |
|
gonadotropin-releasing hormone analog |
2 |
|
gynecological malignancy |
2 |
|
ham56 |
2 |
|
hepatomegaly |
2 |
|
hepatomegaly - complications - pathology - surgery |
2 |
|
histiocytosis, sinus - complications - congenital |
2 |
|
history, 16th century |
2 |
|
hnpcc |
2 |
|
hpv dna test |
2 |
|
hydatidiform mole - blood |
2 |
|
hydatidiform mole - drug therapy - surgery |
2 |
|
hydatidiform mole, invasive - genetics - pathology |
2 |
|
hysteroscopy |
2 |
|
iatrogenic lesions |
2 |
|
immunocompromised host |
2 |
|
infant, newborn |
2 |
|
infarct type necrosis |
2 |
|
interphase cytogenetics |
2 |
|
intestinal metaplasia |
2 |
|
intramyocardial haemorrhage |
2 |
|
keratins - analysis |
2 |
|
kidney - pathology |
2 |
|
leiomyosarcoma - pathology |
2 |
|
leptin |
2 |
|
leptin - biosynthesis |
2 |
|
leptin receptor |
2 |
|
live fetus |
2 |
|
liver neoplasms - radiography - ultrasonography |
2 |
|
lymphoma, b-cell - genetics - pathology |
2 |
|
macrophages, alveolar - immunology |
2 |
|
malignant transformation |
2 |
|
maternal death |
2 |
|
meta-analysis |
2 |
|
metastatic adenocarcinoma |
2 |
|
microtomy |
2 |
|
mifepristone - pharmacology |
2 |
|
mitomycin |
2 |
|
mitomycins - administration & dosage |
2 |
|
mixed tumor, mullerian - diagnosis - pathology |
2 |
|
mixed tumor, mullerian - pathology |
2 |
|
molecular biology |
2 |
|
myocardium - pathology |
2 |
|
myxoid leiomyosarcoma |
2 |
|
neoplasm recurrence, local - epidemiology - pathology |
2 |
|
neoplasms, unknown primary - diagnosis |
2 |
|
neuroblastoma - drug therapy |
2 |
|
observer variation |
2 |
|
oncogene proteins, viral - genetics |
2 |
|
oncogenes |
2 |
|
osteosarcoma - pathology |
2 |
|
ovarian |
2 |
|
ovarian neoplasms |
2 |
|
ovarian neoplasms - drug therapy |
2 |
|
ovulation - drug effects |
2 |
|
palliation |
2 |
|
palliative care |
2 |
|
papillomavirus infections - complications - virology |
2 |
|
papillomavirus infections - epidemiology - prevention & control - virology |
2 |
|
partial mole |
2 |
|
pathology review |
2 |
|
peritoneal fluid |
2 |
|
persistent trophoblastic disease |
2 |
|
peutz-jeghers |
2 |
|
placebos |
2 |
|
placental site nodule/plaque |
2 |
|
placentation |
2 |
|
pleural effusion, malignant - etiology - therapy |
2 |
|
pleurodesis |
2 |
|
postpartum |
2 |
|
precancerous conditions - diagnosis - epidemiology - pathology - physiopathology |
2 |
|
pregnancy complications, hematologic - pathology |
2 |
|
pregnancy complications, neoplastic - diagnosis - epidemiology - pathology - physiopathology |
2 |
|
prenatal diagnosis |
2 |
|
prognostic factors |
2 |
|
protein isoforms |
2 |
|
proto-oncogene proteins - genetics |
2 |
|
proto-oncogene proteins c-bcl-2 - genetics |
2 |
|
puerperal disorders - mortality - pathology |
2 |
|
purpura, thrombotic thrombocytopenic - mortality - pathology |
2 |
|
pyrosequencing |
2 |
|
radioimmunoassay |
2 |
|
radiotherapy - methods |
2 |
|
receptor, trkb - metabolism |
2 |
|
receptors, cell surface - biosynthesis |
2 |
|
receptors, estrogen - antagonists & inhibitors |
2 |
|
receptors, estrogen - biosynthesis |
2 |
|
receptors, fsh - physiology |
2 |
|
receptors, glucocorticoid - metabolism |
2 |
|
receptors, leptin |
2 |
|
receptors, progesterone - biosynthesis |
2 |
|
receptors, progesterone - metabolism |
2 |
|
receptors, somatotropin - physiology |
2 |
|
receptors, steroid - metabolism |
2 |
|
referral and consultation |
2 |
|
repressor proteins |
2 |
|
retroperitoneal neoplasms - metabolism - pathology |
2 |
|
rosai-dorfman disease |
2 |
|
sarcoma |
2 |
|
sarcoma - diagnosis - pathology |
2 |
|
sarcoma, endometrial stromal - diagnosis - pathology |
2 |
|
sarcoma, endometrial stromal - pathology |
2 |
|
selective |
2 |
|
serpins |
2 |
|
significant pathology |
2 |
|
singapore |
2 |
|
sinus histiocytosis with massive lymphadenopathy |
2 |
|
smooth muscle tumor - metabolism - pathology - surgery |
2 |
|
smooth muscle tumor of low malignant potential |
2 |
|
specimen handling |
2 |
|
squamous cell carcinoma antigen |
2 |
|
stem cell |
2 |
|
stomach neoplasms - genetics - pathology |
2 |
|
stromal sarcoma |
2 |
|
taiwan |
2 |
|
tamoxifen |
2 |
|
telomere maintenance mechanism |
2 |
|
teratoma |
2 |
|
teratoma - genetics |
2 |
|
thinprep papanicolaou test |
2 |
|
thrombocytopenia |
2 |
|
thrombocytopenia - complications |
2 |
|
thrombotic thrombocytopaenic purpura |
2 |
|
thyroid neoplasms - genetics |
2 |
|
tissue polypeptide antigen |
2 |
|
tissue polypeptide antigen - blood |
2 |
|
tp53 mutation |
2 |
|
treatment outcome |
2 |
|
trisomy |
2 |
|
trisomy 3 |
2 |
|
trophoblastic neoplasms - blood |
2 |
|
tumor markers, biological - analysis - blood |
2 |
|
tumor markers, biological - blood |
2 |
|
tumor suppressor protein p53 - biosynthesis |
2 |
|
tumor virus infections - complications - virology |
2 |
|
tumour markers |
2 |
|
twins |
2 |
|
twins, dizygotic |
2 |
|
twins, monozygotic |
2 |
|
type distribution |
2 |
|
ubiquitin-protein ligases - biosynthesis |
2 |
|
ultrasonography |
2 |
|
urethral adenocarcinoma |
2 |
|
urethral neoplasms - etiology - metabolism |
2 |
|
urethritis - complications |
2 |
|
urethritis glandularis |
2 |
|
uterine cancer |
2 |
|
uterine cervical neoplasms - blood - pathology |
2 |
|
uterine cervical neoplasms - diagnosis - pathology - physiopathology |
2 |
|
uterine cervical neoplasms - drug therapy - mortality - radiotherapy |
2 |
|
uterine cervical neoplasms - epidemiology - prevention & control - virology |
2 |
|
uterine leiomyoma |
2 |
|
uterine neoplasms - blood |
2 |
|
uterine neoplasms - chemistry - diagnosis - pathology |
2 |
|
uterine neoplasms - metabolism |
2 |
|
uterine neoplasms - metabolism - pathology - surgery |
2 |
|
uterine smooth muscle tumor of uncertain malignant potential (stump) |
2 |
|
uterine smooth muscle tumour of uncertain malignant potential |
2 |
|
vaginal smears - methods |
2 |
|
vaginal smears - statistics & numerical data |
2 |
|
临床生物学行为 |
2 |
|
妊娠滋养 |
2 |
|
异常增生 |
2 |
|
异质 |
2 |
|
形态学 |
2 |
|
性疾病 |
2 |
|
概念 |
2 |
|
滋养细胞疾病 |
2 |
|
滋养细胞肿瘤 |
2 |
|
特征 |
2 |
|
病变 |
2 |
|
abbott realtime high risk hpv test |
1 |
|
abdomen - pathology |
1 |
|
abortion, habitual - genetics |
1 |
|
abortion, spontaneous - genetics |
1 |
|
abscess - complications |
1 |
|
actinomycosis - diagnosis - pathology - surgery |
1 |
|
adenocarcinoma - chemistry - pathology - ultrastructure |
1 |
|
adenocarcinoma - diagnosis |
1 |
|
amniotic fluid embolism |
1 |
|
aneurysm, dissecting - complications - pathology |
1 |
|
angiosarcoma |
1 |
|
antenatal sonography |
1 |
|
autopsy |
1 |
|
birth weight |
1 |
|
calcification |
1 |
|
cancer |
1 |
|
cancer therapy |
1 |
|
carcinoma, squamous cell - diagnosis |
1 |
|
cardiac tamponade - etiology |
1 |
|
cell transformation, neoplastic |
1 |
|
cholangitis |
1 |
|
cholangitis - complications |
1 |
|
choriocarcinoma - pathology |
1 |
|
coronary aneurysm - complications - pathology |
1 |
|
coronary vessels - pathology |
1 |
|
cystectomy - methods |
1 |
|
dataset |
1 |
|
dispermy |
1 |
|
early detection of cancer - methods |
1 |
|
embolism, amniotic fluid - pathology |
1 |
|
emergencies |
1 |
|
endometrial neoplasms - chemistry - pathology - ultrastructure |
1 |
|
endothelial growth factors - analysis |
1 |
|
epithelioid trophoblastic tumour |
1 |
|
expression profiling |
1 |
|
fertilization |
1 |
|
fetal growth retardation - metabolism |
1 |
|
genetic association studies |
1 |
|
genital neoplasms, female - diagnosis |
1 |
|
genital neoplasms, female - diagnosis - genetics |
1 |
|
genital neoplasms, female - metabolism - pathology - physiopathology |
1 |
|
gestational trophoblastic disease - classification - pathology |
1 |
|
gestational trophoblastic disease - genetics - metabolism |
1 |
|
growth substances - physiology |
1 |
|
heart diseases - complications |
1 |
|
hemangioendothelioma - pathology |
1 |
|
hemangioma |
1 |
|
heterozygote detection |
1 |
|
high grade |
1 |
|
hybrid capture 2 |
1 |
|
hydatidiform mole - pathology |
1 |
|
hydatidiform mole, invasive - pathology |
1 |
|
hyperplasia - pathology |
1 |
|
individualised therapy |
1 |
|
infected mural thrombus |
1 |
|
interferon |
1 |
|
interleukin-1beta - secretion |
1 |
|
intermediate trophoblast |
1 |
|
kaposi's sarcoma |
1 |
|
kaposiform hemangioendothelioma |
1 |
|
kasabach-merritt syndrome |
1 |
|
leukocytes, mononuclear - secretion |
1 |
|
low grade |
1 |
|
lymphokines - analysis |
1 |
|
malacoplakia - pathology |
1 |
|
malakoplakia of soft tissue |
1 |
|
maspin |
1 |
|
measurement |
1 |
|
mesenchymoma - diagnosis - pathology |
1 |
|
metaplasia |
1 |
|
michaelis‐gutmann bodies |
1 |
|
molecular diagnostic techniques - methods - trends |
1 |
|
molecular targets |
1 |
|
mutant proteins - metabolism |
1 |
|
mutation, missense - genetics |
1 |
|
myocardial infarction - complications |
1 |
|
neoplasm proteins - physiology |
1 |
|
neoplasm regression, spontaneous |
1 |
|
newborn |
1 |
|
nlrp7 |
1 |
|
oncocyte |
1 |
|
oncogenes - physiology |
1 |
|
organ size |
1 |
|
ovarian cyst |
1 |
|
papillomavirus infections - diagnosis |
1 |
|
perinatal mortality |
1 |
|
peritoneal neoplasms - chemistry - pathology |
1 |
|
placenta - abnormalities - metabolism - pathology |
1 |
|
placenta - anatomy & histology - chemistry |
1 |
|
placenta - cytology - physiology |
1 |
|
polyspermic fertilization |
1 |
|
postpartum hemorrhage - surgery |
1 |
|
protocol |
1 |
|
pseudomyxoma peritonei |
1 |
|
pseudomyxoma peritonei - metabolism - pathology |
1 |
|
receptors, estrogen - analysis |
1 |
|
receptors, progesterone - analysis |
1 |
|
reproduction - genetics |
1 |
|
rupture, spontaneous |
1 |
|
salpingitis - complications - pathology |
1 |
|
sarcoma, kaposi - pathology |
1 |
|
sepsis - etiology |
1 |
|
serpins - biosynthesis - genetics |
1 |
|
skin - pathology |
1 |
|
skin neoplasms - pathology |
1 |
|
staging |
1 |
|
syncytiotrophoblast |
1 |
|
thrombosis - complications |
1 |
|
triploid diandry |
1 |
|
triploidy |
1 |
|
trophoblast marker |
1 |
|
trophoblastic tumor, placental site - pathology |
1 |
|
trophoblastic tumors. |
1 |
|
trophoblasts - chemistry |
1 |
|
trophoblasts - cytology - immunology |
1 |
|
trophoblasts - pathology |
1 |
|
tufted angioma |
1 |
|
tumor markers, biological |
1 |
|
tumor necrosis factor-alpha - secretion |
1 |
|
ultrastructure |
1 |
|
undifferentiated endometrial sarcoma |
1 |
|
urachal cyst - diagnosis - pathology |
1 |
|
urachus - pathology - surgery |
1 |
|
vascular endothelial growth factor |
1 |
|
vascular endothelial growth factor a |
1 |
|
vascular endothelial growth factors |
1 |
|
virology - methods |
1 |
|
y chromosome - genetics |
1 |
|
染色體原位雜交 |
1 |
|
石蠟包埋組織 |
1 |
|
細胞遺傳學 |
1 |
|
組織病理學 |
1 |
|
腫瘤病理診斷 |
1 |
